| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone H3 kinase activity | 1.33e-04 | 12 | 29 | 2 | GO:0140996 | |
| GeneOntologyMolecularFunction | histone kinase activity | 7.52e-04 | 28 | 29 | 2 | GO:0035173 | |
| GeneOntologyMolecularFunction | histone acetyltransferase binding | 8.07e-04 | 29 | 29 | 2 | GO:0035035 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 1.19e-03 | 145 | 29 | 3 | GO:0004713 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 2.51e-03 | 188 | 29 | 3 | GO:0005201 | |
| GeneOntologyMolecularFunction | nuclear estrogen receptor binding | 2.68e-03 | 53 | 29 | 2 | GO:0030331 | |
| GeneOntologyCellularComponent | Golgi lumen | 1.50e-05 | 109 | 29 | 4 | GO:0005796 | |
| GeneOntologyCellularComponent | PML body | 6.81e-04 | 125 | 29 | 3 | GO:0016605 | |
| GeneOntologyCellularComponent | cell-cell junction | 1.20e-03 | 591 | 29 | 5 | GO:0005911 | |
| GeneOntologyCellularComponent | apical junction complex | 1.34e-03 | 158 | 29 | 3 | GO:0043296 | |
| Domain | TIL | 1.42e-04 | 12 | 28 | 2 | PF01826 | |
| Domain | C8 | 1.42e-04 | 12 | 28 | 2 | PF08742 | |
| Domain | Unchr_dom_Cys-rich | 1.67e-04 | 13 | 28 | 2 | IPR014853 | |
| Domain | C8 | 1.67e-04 | 13 | 28 | 2 | SM00832 | |
| Domain | TIL_dom | 1.95e-04 | 14 | 28 | 2 | IPR002919 | |
| Domain | VWFD | 2.57e-04 | 16 | 28 | 2 | PS51233 | |
| Domain | VWD | 2.57e-04 | 16 | 28 | 2 | SM00216 | |
| Domain | VWF_type-D | 2.57e-04 | 16 | 28 | 2 | IPR001846 | |
| Domain | VWD | 2.57e-04 | 16 | 28 | 2 | PF00094 | |
| Domain | VWC_out | 3.65e-04 | 19 | 28 | 2 | SM00215 | |
| Domain | CT | 4.91e-04 | 22 | 28 | 2 | SM00041 | |
| Domain | SEA | 5.38e-04 | 23 | 28 | 2 | PS50024 | |
| Domain | SEA_dom | 5.38e-04 | 23 | 28 | 2 | IPR000082 | |
| Domain | Cys_knot_C | 6.36e-04 | 25 | 28 | 2 | IPR006207 | |
| Domain | CTCK_2 | 6.36e-04 | 25 | 28 | 2 | PS01225 | |
| Domain | FERM_C | 6.89e-04 | 26 | 28 | 2 | PF09380 | |
| Domain | FERM_C | 7.43e-04 | 27 | 28 | 2 | SM01196 | |
| Domain | FERM_PH-like_C | 7.43e-04 | 27 | 28 | 2 | IPR018980 | |
| Domain | FERM_N | 1.11e-03 | 33 | 28 | 2 | IPR018979 | |
| Domain | FERM_N | 1.11e-03 | 33 | 28 | 2 | PF09379 | |
| Domain | VWF_dom | 1.80e-03 | 42 | 28 | 2 | IPR001007 | |
| Domain | FERM_M | 2.15e-03 | 46 | 28 | 2 | PF00373 | |
| Domain | FERM_central | 2.44e-03 | 49 | 28 | 2 | IPR019748 | |
| Domain | FERM_domain | 2.44e-03 | 49 | 28 | 2 | IPR000299 | |
| Domain | - | 2.44e-03 | 49 | 28 | 2 | 1.20.80.10 | |
| Domain | FERM_1 | 2.54e-03 | 50 | 28 | 2 | PS00660 | |
| Domain | FERM_2 | 2.54e-03 | 50 | 28 | 2 | PS00661 | |
| Domain | Band_41_domain | 2.54e-03 | 50 | 28 | 2 | IPR019749 | |
| Domain | B41 | 2.54e-03 | 50 | 28 | 2 | SM00295 | |
| Domain | FERM/acyl-CoA-bd_prot_3-hlx | 2.54e-03 | 50 | 28 | 2 | IPR014352 | |
| Domain | FERM_3 | 2.54e-03 | 50 | 28 | 2 | PS50057 | |
| Domain | - | 2.60e-03 | 391 | 28 | 4 | 2.30.29.30 | |
| Domain | PH_dom-like | 3.54e-03 | 426 | 28 | 4 | IPR011993 | |
| Domain | Ig_2 | 5.33e-03 | 73 | 28 | 2 | PF13895 | |
| Domain | Ion_trans_dom | 1.26e-02 | 114 | 28 | 2 | IPR005821 | |
| Domain | Ion_trans | 1.26e-02 | 114 | 28 | 2 | PF00520 | |
| Domain | Ser/Thr_kinase_AS | 1.59e-02 | 357 | 28 | 3 | IPR008271 | |
| Domain | S_TKc | 1.62e-02 | 359 | 28 | 3 | SM00220 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 9.67e-09 | 16 | 23 | 4 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 1.26e-08 | 17 | 23 | 4 | M27412 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 4.67e-08 | 23 | 23 | 4 | M556 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 7.86e-08 | 26 | 23 | 4 | M27483 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 2.62e-06 | 140 | 23 | 5 | M27484 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 2.82e-06 | 62 | 23 | 4 | M546 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 4.09e-06 | 68 | 23 | 4 | M27303 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 2.87e-05 | 111 | 23 | 4 | M27416 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 7.74e-05 | 143 | 23 | 4 | M27275 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 5.25e-04 | 21 | 23 | 2 | MM15706 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 6.56e-04 | 250 | 23 | 4 | M27554 | |
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 1.18e-09 | 18 | 29 | 4 | 18834073 | |
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 28321513 | ||
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 9422745 | ||
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 11988092 | ||
| Pubmed | 6.71e-07 | 2 | 29 | 2 | 12360467 | ||
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 18300795 | ||
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 19924550 | ||
| Pubmed | Mucin expression in reactive gastropathy: an immunohistochemical analysis. | 2.01e-06 | 3 | 29 | 2 | 17227128 | |
| Pubmed | Expression of mucin 3 and mucin 5AC in arthritic synovial tissue. | 2.01e-06 | 3 | 29 | 2 | 18163520 | |
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 23828549 | ||
| Pubmed | 2.01e-06 | 3 | 29 | 2 | 18825309 | ||
| Pubmed | 2.61e-06 | 486 | 29 | 6 | 20936779 | ||
| Pubmed | 4.02e-06 | 4 | 29 | 2 | 27307198 | ||
| Pubmed | 4.02e-06 | 4 | 29 | 2 | 33154304 | ||
| Pubmed | Prognostic significance of CDX2 and mucin expression in small intestinal adenocarcinoma. | 4.02e-06 | 4 | 29 | 2 | 24603585 | |
| Pubmed | 4.02e-06 | 4 | 29 | 2 | 23807779 | ||
| Pubmed | Gastric mucin expression in first-degree relatives of gastric cancer patients. | 4.02e-06 | 4 | 29 | 2 | 24901817 | |
| Pubmed | Abemaciclib is a potent inhibitor of DYRK1A and HIP kinases involved in transcriptional regulation. | 4.02e-06 | 4 | 29 | 2 | 34785661 | |
| Pubmed | MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significance. | 4.02e-06 | 4 | 29 | 2 | 27298226 | |
| Pubmed | 4.02e-06 | 4 | 29 | 2 | 36367122 | ||
| Pubmed | 4.02e-06 | 4 | 29 | 2 | 17471237 | ||
| Pubmed | 4.02e-06 | 4 | 29 | 2 | 14984930 | ||
| Pubmed | Mucin expression profile in Barrett's, dysplasia, adenocarcinoma sequence in the esophagus. | 4.02e-06 | 4 | 29 | 2 | 17401217 | |
| Pubmed | 4.02e-06 | 4 | 29 | 2 | 12676567 | ||
| Pubmed | Effects of the Helicobacter pylori Virulence Factor CagA and Ammonium Ion on Mucins in AGS Cells. | 4.02e-06 | 4 | 29 | 2 | 29869461 | |
| Pubmed | 4.02e-06 | 4 | 29 | 2 | 12690113 | ||
| Pubmed | 4.02e-06 | 4 | 29 | 2 | 25298197 | ||
| Pubmed | Mucins in neoplastic spectrum of colorectal polyps: can they provide predictions? | 4.02e-06 | 4 | 29 | 2 | 20929551 | |
| Pubmed | 6.70e-06 | 5 | 29 | 2 | 22261707 | ||
| Pubmed | 6.70e-06 | 5 | 29 | 2 | 20940704 | ||
| Pubmed | MUC1, MUC2, MUC4, MUC5AC and MUC6 expression in the progression of prostate cancer. | 6.70e-06 | 5 | 29 | 2 | 16475027 | |
| Pubmed | 1.00e-05 | 6 | 29 | 2 | 17982272 | ||
| Pubmed | 1.00e-05 | 6 | 29 | 2 | 19110483 | ||
| Pubmed | 1.41e-05 | 7 | 29 | 2 | 14609633 | ||
| Pubmed | 3.68e-05 | 11 | 29 | 2 | 24429156 | ||
| Pubmed | DDX3X Suppresses the Susceptibility of Hindbrain Lineages to Medulloblastoma. | 1.83e-04 | 24 | 29 | 2 | 32553121 | |
| Pubmed | Induction of Gastric Cancer by Successive Oncogenic Activation in the Corpus. | 1.99e-04 | 25 | 29 | 2 | 34391772 | |
| Pubmed | 2.88e-04 | 30 | 29 | 2 | 30480076 | ||
| Pubmed | Profiling of tyrosine phosphorylation pathways in human cells using mass spectrometry. | 2.88e-04 | 30 | 29 | 2 | 12522270 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 4.11e-04 | 774 | 29 | 5 | 15302935 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 4.28e-04 | 430 | 29 | 4 | 35044719 | |
| Pubmed | 4.39e-04 | 37 | 29 | 2 | 34147029 | ||
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 4.83e-04 | 444 | 29 | 4 | 34795231 | |
| Pubmed | An approach based on a genome-wide association study reveals candidate loci for narcolepsy. | 5.53e-04 | 193 | 29 | 3 | 20677014 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 6.66e-04 | 861 | 29 | 5 | 36931259 | |
| Interaction | YWHAH interactions | 1.57e-05 | 1102 | 29 | 9 | int:YWHAH | |
| Cytoband | 7q22 | 2.67e-04 | 38 | 29 | 2 | 7q22 | |
| Cytoband | 11p15.5 | 2.54e-03 | 118 | 29 | 2 | 11p15.5 | |
| GeneFamily | CD molecules|Mucins | 7.95e-09 | 21 | 21 | 4 | 648 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 1.52e-03 | 50 | 21 | 2 | 1293 | |
| GeneFamily | Immunoglobulin like domain containing | 2.08e-02 | 193 | 21 | 2 | 594 | |
| Coexpression | NABA_ECM_AFFILIATED | 3.57e-05 | 170 | 29 | 4 | M5880 | |
| Coexpression | GSE34156_UNTREATED_VS_24H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP | 5.98e-05 | 194 | 29 | 4 | M8674 | |
| Coexpression | GSE14308_TH1_VS_NATURAL_TREG_DN | 6.60e-05 | 199 | 29 | 4 | M3381 | |
| Coexpression | GSE12366_PLASMA_CELL_VS_MEMORY_BCELL_DN | 6.60e-05 | 199 | 29 | 4 | M3177 | |
| Coexpression | GSE27786_CD4_TCELL_VS_NEUTROPHIL_DN | 6.73e-05 | 200 | 29 | 4 | M4832 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_DN | 8.76e-05 | 78 | 29 | 3 | M9814 | |
| Coexpression | DESCARTES_FETAL_STOMACH_GOBLET_CELLS | 1.40e-04 | 16 | 29 | 2 | M40303 | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)-D122|Adult / Lineage, Cell type, age group and donor | 7.17e-06 | 193 | 29 | 4 | cc1b6d3bf56e4a88f6fe23dd036a83cf5538c958 | |
| ToppCell | Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.32e-06 | 194 | 29 | 4 | 69cf7c989ac355c459db13f9d4267b55adc3c174 | |
| ToppCell | Children_(3_yrs)-Immune|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.77e-06 | 197 | 29 | 4 | f18807124b91310fcd84238484a80ecdba684679 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 8.09e-06 | 199 | 29 | 4 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | CV-Healthy-3|Healthy / Virus stimulation, Condition and Cluster | 1.35e-04 | 154 | 29 | 3 | 26bf81a86700db7e65c2384ffe94ed4253ea4047 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Radial_glial-gliogenic/outer_RGCs_and_astrocytes|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.42e-04 | 157 | 29 | 3 | 2c1219ee19a6246a3b9f5c2c1a37f26ea934a822 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-04 | 159 | 29 | 3 | 9f6607e395bcca9cb1c83199bdbbaaa62a93938d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-04 | 159 | 29 | 3 | c8b42ebc25ebcc450832096fbffaa5c5f5fe88e7 | |
| ToppCell | CV-Healthy-3|CV / Virus stimulation, Condition and Cluster | 1.53e-04 | 161 | 29 | 3 | fd4a79385ea967b9900dc76a3add813b894a3a28 | |
| ToppCell | Sigmoid-Macrophage-Macrophage|Macrophage / Region, Cell class and subclass | 1.74e-04 | 168 | 29 | 3 | bb16e135b6ae0d66615420b61edd6f62f2a3233c | |
| ToppCell | droplet-Spleen-nan-18m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-04 | 171 | 29 | 3 | 4e856441063e9825b6f87a1d3dd19c77dae4662c | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.93e-04 | 174 | 29 | 3 | d5c22b43531414951666ee7542a66ed9380e2d14 | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.96e-04 | 175 | 29 | 3 | d3890bd0c570bb81434fdd1c5229891cefe2e462 | |
| ToppCell | COVID-19-Heart-VSMC|Heart / Disease (COVID-19 only), tissue and cell type | 2.10e-04 | 179 | 29 | 3 | a69ad6912b5c10bb9f9d800f724c792341e9bab1 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Intestinal_macrophages|lymph-node_spleen / Manually curated celltypes from each tissue | 2.13e-04 | 180 | 29 | 3 | 7be7d7a6906fff6dbdecd9cb013d855aba4eda2a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L3_RORB_CARTPT|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.13e-04 | 180 | 29 | 3 | 5e78b29fa1cbdcf502fee3577e5b45766b90d1dc | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_plasma-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.13e-04 | 180 | 29 | 3 | 8e96f8646c002768b272359af485dc0ab57e0ccd | |
| ToppCell | Control-Myeloid-Alveolar_macrophages|Control / group, cell type (main and fine annotations) | 2.17e-04 | 181 | 29 | 3 | 8d2102c8c86c59a82610f26f90946b290552e666 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-Macrophages|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.20e-04 | 182 | 29 | 3 | ea39b1b5db185b0cb11dfa2e01f3f972effbd770 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.24e-04 | 183 | 29 | 3 | 103c4c4595d8daa677679fd2fa1e99cd398e56dd | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Mac-Macrophage|lymph-node_spleen / Manually curated celltypes from each tissue | 2.24e-04 | 183 | 29 | 3 | 0bcbd60e10b9d6898915dab1987fd46dc7238b19 | |
| ToppCell | 368C-Myeloid-Macrophage-FABP4+_Macrophage_3|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.35e-04 | 186 | 29 | 3 | ddfadd43efeac3b3e6b7062590cc2b8f2f2db2ab | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.38e-04 | 187 | 29 | 3 | 98026c1aaf8de280470ad75536121357934fc78d | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.42e-04 | 188 | 29 | 3 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.42e-04 | 188 | 29 | 3 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.42e-04 | 188 | 29 | 3 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-mo-Mac|normal_Lymph_Node / Location, Cell class and cell subclass | 2.42e-04 | 188 | 29 | 3 | e83de94a9b47a6a90e98face887eae031a322af6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.42e-04 | 188 | 29 | 3 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-04 | 189 | 29 | 3 | 7fbe855bfdb47d35e040b04a80fe4b729a3764e8 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.46e-04 | 189 | 29 | 3 | b13f315f617840eb5143a4e8a33a657c20365c21 | |
| ToppCell | 368C-Myeloid-Macrophage|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.46e-04 | 189 | 29 | 3 | e62355be0d136e2b7c739848022292e9c6af7392 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-04 | 189 | 29 | 3 | 06b35abecd29f902cf251fcc1f6ad33db7ab08a2 | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Mac|lymph-node_spleen / Manually curated celltypes from each tissue | 2.46e-04 | 189 | 29 | 3 | aac79c41ce7acba722c45c016b2c6997fb772a96 | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Mac-Erythrophagocytic_macrophages|lymph-node_spleen / Manually curated celltypes from each tissue | 2.50e-04 | 190 | 29 | 3 | 96c6078619e85f630c9754aca5d6066433e22836 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_2|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.50e-04 | 190 | 29 | 3 | 4cce4ddb79b7751d0103e10f71156977e0c34439 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.50e-04 | 190 | 29 | 3 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | Control-Myeloid|Control / group, cell type (main and fine annotations) | 2.54e-04 | 191 | 29 | 3 | 9c4acc5f3c2f9c0c5520863bb22f391774372347 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.54e-04 | 191 | 29 | 3 | 7065728128e37572b87e6b024374796bd2172e92 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-Tuft-related|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.54e-04 | 191 | 29 | 3 | 7717cf1d99b4451d7145d91367637895f9a2c1c3 | |
| ToppCell | Severe-Myeloid-Macrophages-FABP4+|Severe / Condition, Lineage, Cell class and cell subclass | 2.58e-04 | 192 | 29 | 3 | 30aad927ad40d8abaf9d0539bf8cb9d88d16f24d | |
| ToppCell | Enterocyte_Progenitors-C_06|Enterocyte_Progenitors / shred on cell type and cluster | 2.58e-04 | 192 | 29 | 3 | b9938e1a929c00628cc6ebfdf10cf285167f445c | |
| ToppCell | 368C-Myeloid-Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.62e-04 | 193 | 29 | 3 | c8883731567d0def96e4105dc34b995d1275ddf4 | |
| ToppCell | CTRL-Myeloid-Alveolar_Macrophage|Myeloid / Disease state, Lineage and Cell class | 2.62e-04 | 193 | 29 | 3 | 80871d963c23a6befe58e5e60b7f7d1a1b227ce2 | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage_4|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.62e-04 | 193 | 29 | 3 | b9dcffd28ca309359fb110fb79de8ce066208ee1 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.62e-04 | 193 | 29 | 3 | 52f5b0fbb8ca706206c65e7edbb1ddbd380aebae | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-Myeloid-Macrophages|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.66e-04 | 194 | 29 | 3 | 7c7091de47359760003e910cfbe63db5c99410d6 | |
| ToppCell | 356C-Myeloid-Macrophage|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.66e-04 | 194 | 29 | 3 | 3844e6fb43ae2e0a35ea8ccc1a2e11f40b68bc67 | |
| ToppCell | RA-08._Macrophage|RA / Chamber and Cluster_Paper | 2.66e-04 | 194 | 29 | 3 | ac26e5c71d5069622de72fa25a9c920887ac2c19 | |
| ToppCell | 343B-Myeloid-Macrophage|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.70e-04 | 195 | 29 | 3 | 48ba2044d2459c8b0d17bc7deca8d0195ac6a00e | |
| ToppCell | IIH-mono3-|IIH / Condition, Cell_class and T cell subcluster | 2.70e-04 | 195 | 29 | 3 | 28a858b04a7b413916c07a8d880f5ea02e985461 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.70e-04 | 195 | 29 | 3 | 23ab7e2a419377c05bab0e92a2457afbcd3d9e07 | |
| ToppCell | Immune-alveolar_macrophage_(MARCO_positive)|World / Lineage, Cell type, age group and donor | 2.70e-04 | 195 | 29 | 3 | f92114ef995e690a3bedc62c89c5fd6773d0d9f7 | |
| ToppCell | Monocytes-NUPR1+_Monocytes|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.70e-04 | 195 | 29 | 3 | 5e12201ce7ba912e7faa123ca200e609252ba288 | |
| ToppCell | Control-Myeloid|Control / Disease state, Lineage and Cell class | 2.70e-04 | 195 | 29 | 3 | 46ce2e403ca5d757e5ba17349b6c7ce5cde1f195 | |
| ToppCell | IIH-mono3|IIH / Condition, Cell_class and T cell subcluster | 2.70e-04 | 195 | 29 | 3 | c6dd5af582d257be64b718e30f60220c1bf1738a | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)|Adult / Lineage, Cell type, age group and donor | 2.70e-04 | 195 | 29 | 3 | 55e25f702af19146a161861cfd15f40bbda1dc35 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 2.74e-04 | 196 | 29 | 3 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | 3'_v3-Lung|World / Manually curated celltypes from each tissue | 2.74e-04 | 196 | 29 | 3 | a04f8384b734ce67ec402e64bd891a6274f04744 | |
| ToppCell | (7)_Macrophage|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 2.74e-04 | 196 | 29 | 3 | f1c822860d2a0bae84b0263b0151185756423e0f | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.78e-04 | 197 | 29 | 3 | 0a404b4494a2246d5a92299235056f0fda4d2b48 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.78e-04 | 197 | 29 | 3 | 50f994e0d4e69019ec92e164edf3e4e951333766 | |
| ToppCell | background-Kupffer_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 2.78e-04 | 197 | 29 | 3 | 8b45c7ecc18d188abc8c172d9bf881c95617a46a | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_macrophage-stroma-stromal_macrophage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.78e-04 | 197 | 29 | 3 | 075044c17f1c52008cd3c292c15cbf485b50411e | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Myeloid-Macrophages|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.78e-04 | 197 | 29 | 3 | e698a0bbb20bd4868ff4348f2ac9f609942b55fa | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_neutrophil-granulo-neutrophil-myelocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.82e-04 | 198 | 29 | 3 | c7c5865395992131d0766a03c9c63bad9196b02f | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.82e-04 | 198 | 29 | 3 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_neutrophil-granulo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.82e-04 | 198 | 29 | 3 | 822df797fffbedf63ff8a8d99ea57511ce55f7cf | |
| ToppCell | COVID-19-Myeloid|COVID-19 / group, cell type (main and fine annotations) | 2.82e-04 | 198 | 29 | 3 | 33f0a919188a67d2a876b52c61a1cec2c9747969 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_macrophage|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.82e-04 | 198 | 29 | 3 | 9aaff68107ae4542f904b142d23669f2fcd557ac | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-mature_enterocytic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.82e-04 | 198 | 29 | 3 | e67488695ce5e32ed8d149ed0b841540cbfdd3e2 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.82e-04 | 198 | 29 | 3 | 7696f042648bd53c0a019dfeea68808aa5898615 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_macrophage-macrophage|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.82e-04 | 198 | 29 | 3 | 5aaf3861c53763cf09bb628c9d2eabb6a7277021 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_neutrophil-granulo-neutrophil|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.82e-04 | 198 | 29 | 3 | 9b29232c8b4dcbd81f450f47c3f79bf26c8fb583 | |
| ToppCell | 10x5'-Liver-Myeloid_Mac-Erythrophagocytic_macrophages|Liver / Manually curated celltypes from each tissue | 2.86e-04 | 199 | 29 | 3 | 600afac424416268766fc5c051d4c62ab9eef5de | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_macrophage-stroma-stromal_macrophage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.86e-04 | 199 | 29 | 3 | 2649afa3ccda78e9d1df26127b66cbfa0c6cd01d | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.86e-04 | 199 | 29 | 3 | fde8e3ba19d19069a4d3b8db55bfe6220cf634d5 | |
| ToppCell | COVID-19-Myeloid-Alveolar_macrophages|COVID-19 / group, cell type (main and fine annotations) | 2.86e-04 | 199 | 29 | 3 | e1c85ca85fa22c4a4fa1bbdf55304bf3628485ee | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.86e-04 | 199 | 29 | 3 | 914f66e2b4af323d09fa2340a39cf8051d00a422 | |
| ToppCell | 5'-Adult|5' / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.86e-04 | 199 | 29 | 3 | 8b7b1fcea9a06522fdfab85d0dfd33010ae96d75 | |
| ToppCell | 10x5'-Liver-Myeloid_Mac|Liver / Manually curated celltypes from each tissue | 2.86e-04 | 199 | 29 | 3 | aed138ee879e4e625f177c5bfe0f857a335eb6f2 | |
| ToppCell | 3'_v3-Lung-Myeloid_Mac-Alveolar_macrophages|Lung / Manually curated celltypes from each tissue | 2.86e-04 | 199 | 29 | 3 | eec1b086e5e8b9b0e1770dd269ca903f713d99a8 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac|lymph-node_spleen / Manually curated celltypes from each tissue | 2.86e-04 | 199 | 29 | 3 | c051cc3e42cfa2ec09fd8dae1172af350bb2dfcb | |
| ToppCell | 3'_v3-Lung-Myeloid_Mac|Lung / Manually curated celltypes from each tissue | 2.86e-04 | 199 | 29 | 3 | 1677aaee5b7f5f262e27df5d9f1bdf6e21e3d804 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Erythrophagocytic_macrophages|lymph-node_spleen / Manually curated celltypes from each tissue | 2.86e-04 | 199 | 29 | 3 | 78db2e3b85356ed2f08794e5a97c16a220f8a076 | |
| ToppCell | Sigmoid-Macrophage-Macrophage|Sigmoid / Region, Cell class and subclass | 2.90e-04 | 200 | 29 | 3 | 9ee3a799de7bade1bfe94b6827461633f02bc1dc | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.90e-04 | 200 | 29 | 3 | a443e475e7a10c26a6173d1af961de6219e0e567 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-mo-Mac|Myeloid_cells / Location, Cell class and cell subclass | 2.90e-04 | 200 | 29 | 3 | 195862a319794e57f0506757ae45ab70200bc5b4 | |
| ToppCell | Severe_COVID-19-Myeloid-MoAM4|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 2.90e-04 | 200 | 29 | 3 | 30448a41ca64d6f0fedaff0b7a6670dd33cdf2c5 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.90e-04 | 200 | 29 | 3 | cf720d3973e79ffd4c6e763a7284799ced22a274 | |
| ToppCell | Parenchyma_COVID-19-Immune-TX-TRAM-1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 2.90e-04 | 200 | 29 | 3 | 0a7addc5b2f3f3d91d93bf9d1a466c2acfbcc5de | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM4|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.90e-04 | 200 | 29 | 3 | df821ac12953e44fcfedbbefb35a4976e406ccd6 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM4-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.90e-04 | 200 | 29 | 3 | 4f481d87e30195365900acb5d50641a9e7b2f462 | |
| ToppCell | Sigmoid-(6)_Macrophage|Sigmoid / shred on region, Cell_type, and subtype | 2.90e-04 | 200 | 29 | 3 | 9e10cca4429de2c4c8c3c6cf2c9e28637a095be9 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_alveolar-Macro_alv_MT|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.90e-04 | 200 | 29 | 3 | f11ae9055e72c938b6c9e52701478b2eee681ac4 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.90e-04 | 200 | 29 | 3 | 3e13c9a4ba99a7dfbf738b0fb63fb54b4dee5897 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.90e-04 | 200 | 29 | 3 | ed785a6d08ca2b350dc3307b587eadfb2886d1f9 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM4-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.90e-04 | 200 | 29 | 3 | 5490393c5f54748f912676e19b58bd1320415a06 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-mature_enterocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.90e-04 | 200 | 29 | 3 | 73bfdf068a8ecbefc1e6afe9686df73658ee042f | |
| ToppCell | Sigmoid-Macrophage|Sigmoid / Region, Cell class and subclass | 2.90e-04 | 200 | 29 | 3 | b07ac0ff3b8530e99094678fed80f35949cafac8 | |
| ToppCell | Sigmoid-(6)_Macrophage-(60)_Macrophage|Sigmoid / shred on region, Cell_type, and subtype | 2.90e-04 | 200 | 29 | 3 | ad84a83a5a1893f7b053d39eddeca851463a8ff0 | |
| Drug | rioprostil | 8.99e-06 | 32 | 29 | 3 | CID005311413 | |
| Drug | cellobiitol | 1.40e-05 | 37 | 29 | 3 | CID000003871 | |
| Disease | mucinous adenocarcinoma (is_marker_for) | 9.31e-06 | 5 | 29 | 2 | DOID:3030 (is_marker_for) | |
| Disease | cholangiocarcinoma (is_marker_for) | 3.42e-05 | 64 | 29 | 3 | DOID:4947 (is_marker_for) | |
| Disease | intellectual disability (implicated_via_orthology) | 5.50e-05 | 75 | 29 | 3 | DOID:1059 (implicated_via_orthology) | |
| Disease | gastric ulcer (implicated_via_orthology) | 8.43e-05 | 14 | 29 | 2 | DOID:10808 (implicated_via_orthology) | |
| Disease | Parkinson disease | 2.63e-04 | 321 | 29 | 4 | MONDO_0005180 | |
| Disease | COVID-19 symptoms measurement | 5.44e-04 | 35 | 29 | 2 | EFO_0600019 | |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 5.76e-04 | 36 | 29 | 2 | DOID:11723 (implicated_via_orthology) | |
| Disease | forced expiratory volume | 9.41e-04 | 789 | 29 | 5 | EFO_0004314 | |
| Disease | hair morphology measurement | 1.29e-03 | 54 | 29 | 2 | EFO_0007821 | |
| Disease | idiopathic pulmonary fibrosis | 1.44e-03 | 57 | 29 | 2 | EFO_0000768 | |
| Disease | basophil measurement | 1.59e-03 | 60 | 29 | 2 | EFO_0803539 | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 1.65e-03 | 61 | 29 | 2 | DOID:3587 (is_marker_for) | |
| Disease | radiation-induced disorder | 1.98e-03 | 67 | 29 | 2 | EFO_0009565 | |
| Disease | Hereditary Diffuse Gastric Cancer | 2.93e-03 | 293 | 29 | 3 | C1708349 | |
| Disease | monocyte measurement | 2.95e-03 | 82 | 29 | 2 | EFO_0803547 | |
| Disease | Stomach Neoplasms | 3.04e-03 | 297 | 29 | 3 | C0038356 | |
| Disease | Malignant neoplasm of stomach | 3.13e-03 | 300 | 29 | 3 | C0024623 | |
| Disease | susceptibility to pneumonia measurement | 4.10e-03 | 97 | 29 | 2 | EFO_0008410 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SHHSMTSLSSSTTSS | 651 | Q13627 | |
| SNSTDSTKSQHHSST | 431 | Q6VN20 | |
| SHKTTTHRTTTTGTT | 56 | P34810 | |
| HSTRSTHSTSSHASL | 456 | O60840 | |
| NTAKTSTSLHSHTSS | 1686 | Q6W4X9 | |
| SHTSSTHHAEATSTS | 1696 | Q6W4X9 | |
| STAKTSTSLHSHTSS | 1741 | Q6W4X9 | |
| HSTTLSSGSHSSLST | 2171 | Q6W4X9 | |
| TSHHSSSYKSKSSSN | 991 | Q9H2X6 | |
| RASLSHSSHSSQSSS | 1186 | Q12791 | |
| HSSHSSQSSSKKSSS | 1191 | Q12791 | |
| DSVHSTTSSSDSHDS | 571 | Q13480 | |
| TTKTTSHSTTSFTSS | 766 | Q02505 | |
| KTTSHSTTSFTSSTI | 1521 | Q02505 | |
| FTSSITNTKTTSHSS | 1941 | Q02505 | |
| TTSHSAHSFTSSITT | 2316 | Q02505 | |
| LTKSSTHSDHDNSTS | 161 | Q7Z3B3 | |
| SSASTSHSENSVHTK | 26 | Q13614 | |
| RSSSSESSHSSSSHS | 756 | O75582 | |
| ESSHSSSSHSHGKTT | 761 | O75582 | |
| TASVSKTSTSHVSIS | 3196 | P98088 | |
| KTSTSHVSISKTTHS | 3201 | P98088 | |
| TTSTASVSKTSTSHV | 3491 | P98088 | |
| SKTSTSHVSVSKTTH | 3931 | P98088 | |
| KTSTSHLSVSKTTHS | 4606 | P98088 | |
| KHGKHSSSSSSSSSS | 131 | Q9NZ81 | |
| TASSSAHSTQKDSSH | 976 | Q8NFC6 | |
| EHSRLSHTSSTSSDS | 941 | Q9P2Q2 | |
| LSRHSTASHSSSHTS | 381 | Q96NE9 | |
| TITSSHHSSKTISSL | 31 | Q8NFN8 | |
| ASKASASSSHHSQSS | 746 | Q8IZU9 | |
| SSGSKSHHSHSSSSS | 1091 | Q15648 | |
| SHHSHSSSSSSSAST | 1096 | Q15648 | |
| TSSHESSTHVSSSSS | 586 | O75928 | |
| TFQSSSIKTSTLSHS | 31 | O43364 | |
| KHKTSTAAASSTSTT | 986 | A2VDJ0 | |
| QSSSSSSSHKESSKT | 836 | P51825 | |
| LSSSLSSHQSSLSAH | 701 | Q5T6F2 | |
| SLSAHAALSSSTSHT | 711 | Q5T6F2 | |
| QHSSSSEESTKRTSH | 161 | Q6UX27 | |
| SSHKTPASSSSALSH | 871 | Q9NPG3 | |
| ADTVSSSTTSHTTAK | 176 | Q8NEZ2 | |
| ESTTSHSSTTHTISS | 856 | Q9UKN1 | |
| ESTTSHSSTTHTISS | 3496 | Q9UKN1 |